The global nephrology devices market is experiencing steady expansion, fueled by a rising prevalence of kidney-related disorders such as chronic kidney disease (CKD) and end-stage renal disease (ESRD). The market is valued at USD 15.37 billion in 2024, expected to grow to USD 15.99 billion in 2025, and projected to reach around USD 22.84 billion by 2034, registering a CAGR of 4.04% between 2025 and 2034.
Increasing cases of hypertension and diabetes are directly contributing to the global burden of CKD. This has accelerated the adoption of advanced hemodialysis and peritoneal dialysis devices. Moreover, technological advancements such as AI-powered early diagnostics and home-based kidney care solutions are reshaping the industry.
In 2024, North America held nearly 39% market share, while Asia Pacific is expected to witness the fastest growth through 2034. Among product categories, hemodialysis devices dominated with approximately 47% share in 2024.
Below are the leading players shaping the global nephrology devices landscape:
About: A global leader in kidney care, specializing in dialysis products and services.
Products: Hemodialysis machines, dialyzers, peritoneal dialysis systems.
Market Cap: Approximately USD 20+ billion.
About: A diversified healthcare company with a strong presence in renal care.
Products: Peritoneal dialysis systems, hemodialysis machines, infusion therapies.
Market Cap: Around USD 20 billion.
About: Japan-based manufacturer of medical equipment with a strong nephrology portfolio.
Products: Dialyzers, blood tubing sets, dialysis machines.
Market Cap: Roughly USD 3 billion.
About: German healthcare company with a strong nephrology and urology solutions division.
Products: Hemodialysis systems, peritoneal dialysis solutions, accessories.
Market Cap: Privately held.
About: A global leader in medical technology, increasingly active in kidney care innovations.
Products: Renal denervation systems, dialysis support equipment.
Market Cap: Over USD 100 billion.
About: Japanese multinational with a strong dialysis product line.
Products: Dialyzers, blood purification systems.
Market Cap: About USD 14 billion.
About: Specializes in dialysis technology and water treatment systems for hemodialysis.
Products: Hemodialysis machines, blood tubing lines.
Market Cap: Around USD 500 million.
About: Swiss company focused on innovative renal care solutions.
Products: Dialyzers, dialysis machines.
Market Cap: Private.
About: Japanese manufacturer known for high-quality dialyzers and renal products.
Products: Hemodialysis membranes, peritoneal dialysis equipment.
Market Cap: Private (subsidiary of Toray Industries).
About: Japanese medical device manufacturer with a strong dialysis segment.
Products: Dialyzers, tubing sets, hemodialysis accessories.
Market Cap: Around USD 1 billion.
About: US-based medical technology company known for its portable dialysis systems.
Products: Tablo Hemodialysis System.
Market Cap: Approximately USD 250 million.
About: UK-based company developing compact dialysis solutions for home use.
Products: SC+ hemodialysis system.
Market Cap: Private.
About: Focuses on renal therapies and dialysis-related pharmaceuticals.
Products: Hemodialysis concentrates, iron maintenance therapy.
Market Cap: Around USD 30 million.
About: South Korean medical device maker with dialysis support solutions.
Products: Patient monitoring, dialysis equipment accessories.
Market Cap: Approx. USD 100 million.
About: Acquired by Fresenius, specializing in home hemodialysis systems.
Products: NxStage System One portable dialysis machine.
Market Cap: Part of Fresenius.
About: Singapore-based startup pioneering portable kidney dialysis systems.
Products: Wearable artificial kidney technology.
Market Cap: Private.
About: Baxter’s renal care arm, integrating Gambro’s advanced dialysis technology.
Products: Hemodialysis and peritoneal dialysis machines.
Market Cap: Part of Baxter.
About: Focused on comprehensive kidney treatment solutions.
Products: Dialysis services, home-based renal care.
Market Cap: Private.
About: India-based manufacturer of dialysis and nephrology devices.
Products: Dialysis machines, dialyzers, blood tubing.
Market Cap: Private.
The global nephrology devices market will continue to evolve with AI-driven diagnostics, portable dialysis machines, and personalized kidney care solutions. The shift towards home-based dialysis treatments will open up new opportunities for players across regions.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
Q1: What is the current size of the global nephrology devices market?
A1: The market size is estimated at USD 15.37 billion in 2024 and is projected to reach USD 22.84 billion by 2034.
Q2: Which region dominates the nephrology devices market?
A2: North America holds the largest market share, accounting for about 39% in 2024.
Q3: What are the major drivers of the market?
A3: Rising cases of CKD and ESRD, technological advancements, and increasing adoption of home-based dialysis solutions.
Q4: Which product segment leads the market?
A4: Hemodialysis devices dominate with around 47% market share in 2024.
Q5: Who are the top companies in this market?
A5: Key players include Fresenius Medical Care, Baxter, Nipro, B. Braun, Medtronic, and others listed above.
Source : https://www.towardshealthcare.com/insights/nephrology-devices-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5922
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More